Department of Health and Ageing [2008] AUSStaCSDLM 32 (13 March 2008)

• DEPARTMENT OF HEALTH AND AGEING

DEPARTMENT OF HEALTH AND AGEING

Health Insurance (Permitted Benefits — Diagnostic Imaging Services) Determination 2008 under s. 23DZZIG of the Health Insurance Act 1973 [F2008L00615]
Health Insurance Act 1973
Made	19/02/2008
Tabled	11/03/2008 S	11/03/2008 HR
Summary	Specifies benefits that are permitted in relation to diagnostic imaging services.

Health Insurance (Permitted Benefits — Pathology Services) Determination 2008 under s. 23DZZIG of the Health Insurance Act 1973 [F2008L00616]
Health Insurance Act 1973
Made	19/02/2008
Tabled	11/03/2008 S	11/03/2008 HR
Summary	Specifies benefits that are permitted benefits in relation to pathology services.

Instrument No. PB 31 of 2008 under ss. 85, 85A and 88 of the National Health Act 1953 [F2008L00692]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Specifies a revised list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 32 of 2008 under s. 84AF of the National Health Act 1953 [F2008L00696]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Determines, for specified brands of pharmaceutical items, the responsible persons for those brands.

Instrument No. PB 33 of 2008 under s. 85B of the National Health Act 1953 [F2008L00698]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Amends the list of drugs and medicinal preparations that are available as pharmaceutical benefits.

Instrument No. PB 34 of 2008 under paragraph 98C(1)(b) of the National Health Act 1953 [F2008L00699]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Specifies conditions under which payments will be made in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners.

Instrument No. PB 36 of 2008 under s. 100(1) of the National Health Act 1953 [F2008L00701]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Amends the arrangements for the availability of drugs and medicinal preparations under the Highly Specialised Drugs Program.

Instrument No. PB 37 of 2008 under s. 100(1) of the National Health Act 1953 [F2008L00702]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Amends the arrangements for the availability of special pharmaceutical products to persons who require treatment with chemotherapy pharmaceuticals.

Instrument No. PB 39 of 2008 under s. 85AB of the National Health Act 1953 [F2008L00703]
National Health Act 1953
Made	03/03/2008
Tabled	13/03/2008 S	13/03/2008 HR
Summary	Specifies drugs that are assigned to the F1 formulary.

National Health (Immunisation Program — Designated Vaccines) Determination 2008 under ss. 9B(2) and 9B(5) of the National Health Act 1953 [F2008L00641]
National Health Act 1953
Made	25/02/2008
Tabled	11/03/2008 S	11/03/2008 HR
Summary	Replaces and amends a previous Determination.

Privacy Guidelines for the Medicare Benefits and Pharmaceutical Benefits Programs under s. 135AA of the National Health Act 1953 [F2008L00706]
National Health Act 1953
Made	06/03/2008
Tabled	12/03/2008 S	12/03/2008 HR
Summary	Specify revised guidelines concerning the handling by Government agencies of information obtained in connection with claims for payment or benefit under the Medicare Benefits and Pharmaceutical Benefits Programs.

Therapeutic Goods (Listing) Notice 2008 (No. 1) under s. 9A(5) of the Therapeutic Goods Act 1989 [F2008L00384]
Therapeutic Goods Act 1989
Made	04/02/2008
Tabled	11/03/2008 S	18/02/2008 HR
Summary	Permits the use of sodium fluoride as an active ingredient in listed medicines for oral use with certain conditions.

Therapeutic Goods (Listing) Notice 2008 (No. 2) under s. 9A(5) of the Therapeutic Goods Act 1989 [F2008L00385]
Therapeutic Goods Act 1989
Made	04/02/2008
Tabled	11/03/2008 S	18/02/2008 HR
Summary	Permits the use of krill oil as an active ingredient in listed complementary medicines for oral use.